Control of the ratio of LAP to LIP

作者: Yohei Hirai

DOI:

关键词:

摘要: The present invention provides recombinant gene vectors and nucleic acid constructs which are capable of decreasing, reducing or suppressing the transcription/translation LIP (transcription inhibitor protein), in some examples, without affecting LAP activator). Such used methods for increasing ratio to activity a cell treating and/or ameliorating symptoms disease condition associated with LIP. also screening agents that modifying individual.

参考文章(19)
Cynthia A. Zahnow, Robert D. Cardiff, Jeffrey M. Rosen, Daniel Medina, Rodolfo Laucirica, A Role for CCAAT/Enhancer Binding Protein β-Liver-enriched Inhibitory Protein in Mammary Epithelial Cell Proliferation Cancer Research. ,vol. 61, pp. 261- 269 ,(2001)
Hedi Haddada, Manuel Lopez, Michel Perricaudet, Recombinant cells from the monocyte-macrophage cell line for gene therapy ,(1994)
Hedi Mohamed Haddada, Michel Perricaudet, Thierry Ragot, Defective recombinant adenoviruses expressing cytokines for antitumor treatment ,(1998)
Barrie J. Carter, Jon D. Tratschin, Adeno-associated virus as eukaryotic expression vector ,(1985)
Friedrich Scheiflinger, Friedrich Dorner, Falko Gunter Falkner, Michael Pfleiderer, Methods for generating immune responses employing modified vaccinia of fowlpox viruses ,(1996)
Nicholas Muzyczka, Richard J. Samulski, Kenneth I. Berns, Paul L. Hermonat, AAV transduction vectors ,(1991)
Madeline M. Butler, Brett P. Monia, Jacqueline Wyatt, Antisense inhibition of C/EBP alpha expression Official Gazette of the United States Patent and Trademark Office Patents. ,(2000)
Yohei Hirai, Derek Radisky, Rosanne Boudreau, Marina Simian, Mary E. Stevens, Yumiko Oka, Kyoko Takebe, Shinichiro Niwa, Mina J. Bissell, Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbeta Journal of Cell Biology. ,vol. 153, pp. 785- 794 ,(2001) , 10.1083/JCB.153.4.785